Frontier Medicines

Frontier Medicines Announces Three Executive Hires: Chief Scientific Officer, Chief Technology Officer & Head of Degrader Technologies

Frontier Medicines launches with $67 million to develop novel medicines that drug the “undruggable” targets driving human disease

admin

Leave a comment

Your email address will not be published. Required fields are marked *